Daniel J George

32PUBLICATIONS
122CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|Jun 20, 2026
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Apr 01, 2026
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial).

Santosh Gupta, Siyuan Guo, Susan Halabi

|Mar 19, 2026
Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study.

Neal D Shore, Daniel J George, Nasreen Khan

|Jan 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence.

Muthana Al Abo, Wen-Chi Foo, Lauren E Howard

Pageof 6

Frequent Collaborators

14 joint publications

Andrew J Armstrong

7 joint publications

Susan Halabi

5 joint publications

Michael R Harrison

4 joint publications

Tian Zhang